Clinical Trials Insight: 700019981

Trial Profile

Clinical Trials Insight: 700019981

Phase of Trial: Phase II

Latest Information Update: 10 Aug 2007

At a glance

  • Drugs Eprotirome (Primary)
  • Indications Dyslipidaemias; Hypercholesterolaemia
  • Focus Therapeutic Use
  • Sponsors Karo Bio
  • Most Recent Events

    • 10 Aug 2007 Results from this study will be presented at the Drugs Affecting Lipid Metabolism (DALM) meeting in New York from 4-7 October 2007.
    • 12 Jun 2007 Status changed from recruiting to completed.
    • 22 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top